Endothelial cell DNA transfer and expression using Petri dish electroporation and the nonreplicating vaccinia virus/T7 RNA polymerase hybrid system

Gene Therapy

Volumn 6, Issue 9, 1999, Pages 1617-1625

  Lewis, E W ^a   Rudo, T J ^a   Rahman St John, M A ^b   Chu, J L ^a   Heinze, A W ^a   Howard, B H ^b   Engleka, K A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Electroporation; Endothelia cell; Expression; Transfection; Vaccinia virus

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA DIRECTED RNA POLYMERASE; FIBROBLAST GROWTH FACTOR 1; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2 RECEPTOR; PROTEIN KINASE P60; PROTEIN P21; PROTEIN P27; RECEPTOR SUBUNIT; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL SELECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA TRANSFER; ELECTRIC POTENTIAL; ELECTRODE; ELECTROPORATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VACCINIA VIRUS; VASCULAR ENDOTHELIUM;

BACTERIOPHAGE T7; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA-DIRECTED RNA POLYMERASES; ELECTROPORATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOBLOTTING; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; RECEPTORS, INTERLEUKIN-2; UMBILICAL VEINS; VACCINIA VIRUS; VIRAL PROTEINS;

CYTOMEGALOVIRUS; FELIS CATUS; VACCINIA; VACCINIA VIRUS;

EID: 0032877231     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300977     Document Type: Article

References (46)

1. Schwachtgen J-L, Ferreira V, Meyer D, Kerbiriou-Nabias D. Optimization of the transfection of human endothelial cells by electroporation. BioTechniques 1994; 17: 882-887.
2. Tanner FC, Carr DP, Nabel GJ, Nabel EG. Transfection of human endothelial cells. Cardiovascular Res 1997; 35: 522-528.
3. Teifel M, Heine L-T, Milbredt S, Friedl P. Optimization of transfection of human endothelial cells. Endothelium 1997; 5: 21-35.
4. Edgell C-JS, Curiel DT, Hu P-C, Marr HS. Efficient gene transfer to human endothelial cells using DNA complexed to adenovirus particles. BioTechniques 1998; 25: 264-272.
5. Fife K et al. Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing. Gene Therapy 1998; 5: 614-620.
6. Wilson DB, Dorfman DM, Orkin SH. A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol Cell Biol 1992; 10: 4854-4862.
7. Nabel EG, Nabel GJ. Complex models for the study of gene function in cardiovascular biology. Ann Rev Physiol 1994; 56: 741-761.
8. Inaba M et al. Retroviral gene transfer: effects on endothelial cell phenotype. J Surg Res 1998; 78: 31-36.
9. de Martin R, Raidl M, Hofer E, Binder BR. Adenovirus-mediated expression of green fluorescent protein. Gene Therapy 1997; 4: 493-495.
10. Riccioni T et al. Adenovirus-mediated wild-type p53 over-expression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo. Gene Therapy 1998; 5: 747-754.
11. Engleka KA, Lewis EW, Howard BH. Mechanisms of replication-deficient vaccinia virus/T7 RNA polymerase hybrid expression; effect of T7 RNA polymerase levels and alpha-amanitin. Virology 1998; 243: 331-339.
12. Sutter G, Moss B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc Natl Acad Sci USA 1992; 89: 10847-10851.
13. Sutter G, Olmann M, Erfle V. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 1995; 371: 9-12.
14. Wyatt LS, Moss B, Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 1995; 210: 202-205.
15. Moss B et al. New mammalian expression vectors. Nature 1990; 348: 91-92.
16. Muramatsu T, Nakamura A, Park H-M. In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals. Int J Mol Med 1998; 1: 55-62.
17. Nathwani AC et al. Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter. Br J Haematol 1994; 88: 122-128.
18. Elroy-Stein O, Moss B. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci USA 1990; 87: 6743-6747.
19. Giordano T et al. Isolation of a population of transiently transfected quiescent and senescent cells by magnetic affinity cell sorting. Exp Cell Res 1991; 192: 193-197.
20. Padmanabhan R et al. Purification of transiently transfected cells by magnetic affinity cell sorting. Anal Biochem 1988; 170: 341-348.
21. Prasher DC et al. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 1992; 111: 229-233.
22. Harper JW et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
23. Jaye M et al. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science 1986; 233: 541-545.
24. DeCaprio JA et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275-283.
25. Ewen ME, Xing Y, Lawrence JB, Livingston D. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107. a retinoblastoma gene product-related protein. Cell 1991; 66: 1155-1164.
26. Mayol X et al. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 1993; 8: 2561-2566.
27. Tanaka A et al. DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol 1987; 7: 1978-1983.
28. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
29. Moss B et al. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Adv Exp Med Biol 1996; 397: 7-13.
30. Bender BS et al. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J Virol 1996; 70: 6418-6424.
31. Sutter G et al. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 1994; 12: 1032-1040.
32. Schneider J et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med 1998; 4: 397-402.
33. Hanke T et al. Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type I in mice. J Gen Virol 1998; 79: 83-90.
34. Mayr A, Hochstein-Mintzel V, Stickl H. Passage history, properties, and applicability of the attenuated vaccinia virus strain MVA. Infection 1973; 3: 6-14.
35. van den Hoff MJB, Moorman AFM, Lamers WH. Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res 1992; 20: 2902.
36. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
37. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2746.
38. Vuento M, Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 1979; 183: 331-337.
39. Regnault V, Rifat C, Stoltz JF. Affinity purification of human plasma fibronectin on immobilized gelation. J Chromatogr 1988; 432: 93-102.
40. Maciag T, Weinstein R, Preparation of endothelial cell growth factor. In: Barnes DW, Sirbasku DA, Sato GH (eds). Methods for Preparation of Media, Supplements, and Substrata for Serum-free Animal Cell Culture. Alan R Liss: New York, 1984, pp 195-205.
41. Elroy-Stein O, Fuerst TR, Moss B. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci USA 1989; 86: 6126-6130.
42. Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 1989; 86: 6077-6081.
43. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 1044-1051.
44. Leonard WJ et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 1984; 311: 626-631.
45. Goldstein S, Fordis CM, Howard BH. Enhanced transfection efficiency and improved cell survival after electroporation of G2/M-synchronized cells and treatment with sodium butyrate. Nucleic Acids Res 1989; 17: 3959-3971.
46. Fordis CM, Howard BH. Use of the CAT reporter gene for optimization of gene transfer into eukaryotic cells. Meth Enzymol 1987; 151: 382-397.